A novel antagonist anti-cMet antibody with antitumor activities targeting both ligand-dependent and ligand-independent c-Met receptors

Publié en
Auteur

Gonzalez A, Broussas M, Beau-Larvor C, Haeuw JF, Boute N, Robert A, Champion T, Beck A, Bailly C, Corvaia N, Goetsch L

 

Int. J. Cancer. 2016 Oct 15;139(8):1851-63